Primoris

Provider of exosome-based aesthetic solutions, derma cosmetics, and raw materials

placeSeoul, Seoul, South Korea calendar_todayFounded 2017 groups9 employees language primorisintl.com

Innovation

5 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 55 times.

YearFilings
20211
20223
20234
20242

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon